BR9714355A - Novos agonistas de receptor flt3 - Google Patents

Novos agonistas de receptor flt3

Info

Publication number
BR9714355A
BR9714355A BR9714355-3A BR9714355A BR9714355A BR 9714355 A BR9714355 A BR 9714355A BR 9714355 A BR9714355 A BR 9714355A BR 9714355 A BR9714355 A BR 9714355A
Authority
BR
Brazil
Prior art keywords
receptor agonists
new
flt3 receptor
flt
receptor agonist
Prior art date
Application number
BR9714355-3A
Other languages
English (en)
Inventor
Charles A Mcwherter
Yiqing Feng
John P Mckearn
Nicholas R Statenr
Philip R Streeter
Susan L Woulfe
Nancy I Minster
John C Minnerly
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Publication of BR9714355A publication Critical patent/BR9714355A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Patente de Invenção: <B>"NOVOS AGONISTAS DE RECEPTOR flt3"<D>. Descrevem-se novas proteínas de agonista de receptor flt-3, DNAs que codificam as proteínas de agonistas de receptor flt-3, processos para fazer as proteínas de agonistas de receptor flt-3 e processos para usar as proteínas de agonistas de receptor flt-3.
BR9714355-3A 1996-10-25 1997-10-23 Novos agonistas de receptor flt3 BR9714355A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3009496P 1996-10-25 1996-10-25
PCT/US1997/018700 WO1998018923A1 (en) 1996-10-25 1997-10-23 NOVEL flt-3 RECEPTOR AGONISTS

Publications (1)

Publication Number Publication Date
BR9714355A true BR9714355A (pt) 2000-04-11

Family

ID=21852464

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9714355-3A BR9714355A (pt) 1996-10-25 1997-10-23 Novos agonistas de receptor flt3

Country Status (7)

Country Link
US (2) US6660257B1 (pt)
EP (1) EP0950099A1 (pt)
JP (1) JP2001503265A (pt)
AU (1) AU733964B2 (pt)
BR (1) BR9714355A (pt)
CA (1) CA2268027A1 (pt)
WO (1) WO1998018923A1 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5581476A (en) 1993-01-28 1996-12-03 Amgen Inc. Computer-based methods and articles of manufacture for preparing G-CSF analogs
US6291661B1 (en) 1998-07-02 2001-09-18 Immunex Corporation flt3-L mutants and method of use
AU2001239873A1 (en) * 2000-02-24 2001-09-03 The Board Of Trustees Of The Leland Stanford Junior University Adjuvant treatment by in vivo activation of dendritic cells
AU2002329176A1 (en) * 2001-05-25 2002-12-23 The Trustees Of The University Of Pennsylvania Targeted particles and methods of using the same
ATE468862T1 (de) 2001-07-11 2010-06-15 Maxygen Inc G-csf konjugate
US7256038B2 (en) 2003-08-18 2007-08-14 Regents Of The University Of California Polypeptide display libraries and methods of making and using thereof
US7756681B2 (en) 2005-03-10 2010-07-13 Hewlett-Packard Development Company, L.P. Power supply circuit
US7506180B2 (en) * 2005-03-10 2009-03-17 Hewlett-Packard Development Company, L.P. System and method for determining the power drawn from a switching power supply by counting the number of times a switching power supply switch is enabled
US7381805B2 (en) 2005-06-01 2008-06-03 Maxygen Holdings, Ltd. Compositions comprising mixtures of positional PEG isomers of PEGylated G-CSF
EP2535346B1 (en) 2005-08-31 2017-08-02 The Regents of The University of California Cellular libraries of peptide sequences (CLiPS) and methods of using the same
WO2009014726A1 (en) 2007-07-26 2009-01-29 The Regents Of The University Of California Methods for enhancing bacterial cell display of proteins and peptides
US8921516B2 (en) * 2010-12-08 2014-12-30 Corning Incorporated Synthetic, defined fibronectin mimetic peptides and surfaces modified with the same
AU2015243849B2 (en) 2014-04-10 2020-12-17 Seattle Children's Hospital (dba Seattle Children's Research Institute) Transgene genetic tags and methods of use
JP7162530B2 (ja) 2015-08-07 2022-10-28 シアトル チルドレンズ ホスピタル （ディービーエイ シアトル チルドレンズ リサーチ インスティテュート） 固形腫瘍を標的とする二重特異性ｃａｒ ｔ細胞
CA3048648A1 (en) 2017-01-10 2018-07-19 The General Hospital Corporation T cells expressing a chimeric antigen receptor
WO2019140127A2 (en) * 2018-01-10 2019-07-18 The General Hospital Corporation Immune cells expressing a chimeric antigen receptor
CN113544152B (zh) 2018-12-18 2024-10-15 勃林格殷格翰国际加拿大公司 Flt3激动剂抗体及其用途
CA3133830A1 (en) * 2019-03-28 2020-10-01 Orionis Biosciences, Inc. Fms-like tyrosine kinase 3 ligand (flt3l)-based chimeric proteins

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0699236B2 (en) 1993-05-19 2006-06-14 Schering Corporation Purified mammalian flt3 ligands and agonists and antagonists thereof
US5554512A (en) 1993-05-24 1996-09-10 Immunex Corporation Ligands for flt3 receptors
NZ314644A (en) 1993-05-24 2000-11-24 Immunex Corp Use of flt3-ligands as a growth stimulator of stem cells in the transplantation of tissue
CN1122716C (zh) 1994-03-07 2003-10-01 依默耐克斯有限公司 体外细胞培养和移植试剂盒
US5635599A (en) 1994-04-08 1997-06-03 The United States Of America As Represented By The Department Of Health And Human Services Fusion proteins comprising circularly permuted ligands
CN1590407A (zh) 1995-10-05 2005-03-09 G.D.瑟尔公司 多功能性造血受体激动剂

Also Published As

Publication number Publication date
AU733964B2 (en) 2001-05-31
EP0950099A1 (en) 1999-10-20
WO1998018923A1 (en) 1998-05-07
AU4985397A (en) 1998-05-22
US6660257B1 (en) 2003-12-09
CA2268027A1 (en) 1998-05-07
JP2001503265A (ja) 2001-03-13
US20040127410A1 (en) 2004-07-01

Similar Documents

Publication Publication Date Title
BR9712675A (pt) Agonistas do receptor de eritropoietina circularmente permutados.
BR9916896A (pt) Diaril aminas substituìdas com 1-heterociclo
SG157952A1 (en) Small molecule antagonists of bcl-2 family proteins
AU6391299A (en) Methods of identifying inverse agonists of the serotonin 2a receptor
ATE369131T1 (de) Verwendung von agonisten des zentralen cannabinoid-rezeptors cb1
BR9912649A (pt) Naftopiranos anelados em c5-c6, suas preparaçõese composições, e matrizes (co) polìmerascontendo-os
CA2251842A1 (en) Small molecule mimetics of erythropoietin
DK0736525T3 (da) Benzonitriler som 5-HT-agonister og -antagonister
ES2190246T3 (es) Nuevos compuestos de tiazolopirimidina.
DE69725611D1 (de) Nicht-Nukleotid verknüpfende Reagentien
AR016981A2 (es) Polipeptidos sinteticos
BR9813140A (pt) Indol naftopiranos, preparação, composições e as matrizes ( co ) polìmeras contendo-as, sìntese dos intermediários
MX9802730A (es) Agonistas receptores hematopoyeticos multifuncionales.
BR9713668A (pt) Agonistas de receptores hematopoiéticos quiméricos multifuncionais
EA199800867A1 (ru) Соединения тетрагидробетакарболина
NO990849L (no) Substituerte 1,2,3,4-tetrahydro-2-dibenzofuranaminer og 2-aminocyklohepta (b) benzofuraner
IL122606A (en) (S)-hydroxa-nitrile-lyase
DK1363944T3 (da) Höjaffinitetsantagonister for ELR-CXC-kemokiner
MY127474A (en) Naphthyl compounds, intermediates, compositions, and methods of use
AU4178497A (en) HTm4, methods of treatment and assays, agonists and antagonists
BR9808514A (pt) Proteìnas quiméricas do ligante flt3
EA200000112A1 (ru) Новая композиция
PE20399A1 (es) Muteina ob
BR9909252A (pt) Proteìnas de interação caspase-8
WO2000001821A3 (en) Neurotransmission associated proteins

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE COMO INVENCAO, DE ACORDO COM ARTIGO 8O DA LPI